Arkolith/Insider Trading/TNYA/Form 4

Ali Faraz

Chief Executive Officer, DirectorTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Mar 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Sell(S)4K$0.54$2K321K
Mar 10, 2025Sell(S)6K$0.54$3K324K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-036770) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML